| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 16451 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Allergenextrakt aus ausschl. Wiesenlieschgraspollen (ausschl. SUT), ATC V01AA02 f. d. Z. 01.10.24-30.09.26 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16452 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Faricimab, ATC S01LA09 (OBO) für die Zeit 01.10.2024 - 30.09.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16453 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dapagliflozin, ATC A10BK01 (OBO) für die Zeit 01.10.2024 - 30.09.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16454 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bimekizumab, ATC L04AC21 (OBO) für die Zeit 01.10.2024 - 30.09.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16455 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dapagliflozin + Metformin, ATC A10BD15 (OBO) für die Zeit 01.10.2024 - 30.09.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16456 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Abirateron (ausgenommen Wirkstärke 500 mg), ATC L02BX03 (OBG) für die Zeit 01.10.2024 - 30.09.2026 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16457 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Telmisartan, ATC C09CA07 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16458 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Febuxostat, ATC M04AA03 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16459 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Glyceroltrinitrat, ATC C01DA02 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16460 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Mesalazin, ATC A07EC02 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16461 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Pomalidomid, ATC L04AX06 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16462 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Lacosamid (ausgenommen Darreichungsform Filmtabletten), ATC N03AX18 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16463 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Treprostinil, ATC B01AC21 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16464 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Raltegravir, ATC J05AJ01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16465 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Miglustat, ATC A16AX06 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16466 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2024-08 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16467 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16468 | Germany – Pharmaceutical products – OpenHouse-Verfahren Diverse Arzneimittelwirkstoffe ab 01.10.2024 Buyer: AOK Rheinland/Hamburg - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline:... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland/Hamburg - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-05 |
||||||
| 16469 | Recrutement d’un cabinet chargé de la formation sur la norme de bâtiments, la révision et vulgarisation du guide sur les cases traditionnelles et l’opérationnalisation du guide méthodologique pour l’intégration de l’ACC et de la GRC dans les SRAT et PRD PRIMATURE----------CELLULE DE PREVENTION ET D’APPUI A LA GESTION DES URGENCES (CPGU)---------PROJET REGIONAL... | Procurement Procurement Contract | Africa | Not provided on the source page. Please check the official source. | Deadline Soon Aug 5, 2026 Open | World Bank Procurement Opportunities |
|
Source description
PRIMATURE----------CELLULE DE PREVENTION ET D’APPUI A LA GESTION DES URGENCES (CPGU)---------PROJET REGIONAL POUR LA RESILIENCE CLIMATIQUE PRRC (P180171, IDA N°7326-MG) SOLLICITATION DE MANIFESTATIONS D’INTERET (SERVICES DE CONSEIL-SELECTION DES FIRMES) SELECTION DE CONSULTANTS PAR LES EMPRUNTEURS DE LA BANQUE MONDIALE MADAGASCARPROJET REGIONAL POUR LA RESILIENCE CLIMATIQUE – PRRCP180171, IDA N°7326-MGAPPEL A MANIFESTATION D’INTERET EN VUE DE LA SELECTION D’UN BUREAU D’ETUDES EN CHARGE DE LA FORMATION SUR LA NORME DE BATIMENTS, LA REVISION ET VULGARISATION DU GUIDE SUR LES CASES TRADITIONNELLES ET L’OPERATIONNALISATION DU GUIDE METHODOLOGIQUE POUR L’INTEGRATION DE L’ACC ET DE LA GRC DANS LES SRAT ET PRD AMI N° 05-2026/C054/CPGU/PRRCN° de référence (selon le Plan de Passation des marchés) : MD-CPGU-C054 Le Gouvernement de la République de Madagascar a reçu un financement de la Banque mondiale pour couvrir le coût du Projet Régional pour la Résilience Climatique (PRRC), et a l'intention d’utiliser une partie du montant de ce prêt pour effectuer les paiements au titre du contrat suivant « FORMATION SUR LA NORME DE BATIMENTS, LA REVISION ET VULGARISATION DU GUIDE... |
||||||
| 16470 | Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Trainin... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Deadline Soon Aug 6, 2026 Open | Grants.gov |
|
Source description
This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-infections in HIV infected individuals or infections associated with non-communicable disease conditions of public health importance in LMICs. Training related to prevention, treatment or public health approaches to any technical area of basic, epidemiology, clinical, behavioral or social science health research may be supported. Research Training programs should incorporate didactic, mentored research and career development skills components to prepare individuals for careers that will have significant impact on the priority health research needs of LMICs. This Funding Opportunity Announcement (FOA) allows support of [trainees] as the lead investigator of an independent clinical trial; or a separate ancillary clinical trial or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development. |
||||||
| 16471 | Fiscal Year 2024 Flood Mitigation Assistance The Flood Mitigation Assistance (FMA) grant program makes federal funds available to states, U.S. territories, federally recognize... | Grant Cash Grant | United States | Award range: $0 - $0 | Deadline Soon Aug 6, 2026 Open | Grants.gov |
|
Source description
The Flood Mitigation Assistance (FMA) grant program makes federal funds available to states, U.S. territories, federally recognized tribal governments, and local governments to reduce or eliminate the risk of repetitive flood damage to buildings and structures insured under the National Flood Insurance Program (NFIP) in participating communities. FMA funds a variety of flood mitigation activities that are designed to reduce flood risk to policyholders in an effort to reduce the NFIP’s financial exposure.Applicants can submit applications for this funding opportunity through FEMA Grants Outcomes (GO). Access the system at https://go.fema.gov/ |
||||||
| 16472 | High-performance Optimized Recycled Nuclear Isotopes for Gen IV reactors (HORNIG) This is Modification 01 to the NOFO: • Inserted certain deadlines and updated dates, including the deadlines for submitting questi... | Grant Mixed | United States | Award range: $500,000 - $7,000,000 | Deadline Soon Aug 6, 2026 Open | Grants.gov |
|
Source description
This is Modification 01 to the NOFO: • Inserted certain deadlines and updated dates, including the deadlines for submitting questions and Full Applications (Basic Information, Section IV.C). NOFO Number: DE-FOA-0003623 – High-performance Optimized Recycled Nuclear Isotopes for Gen IV reactors (HORNIG) Agency Overview: The Advanced Research Projects Agency—Energy (ARPA-E), an organization within the Department of Energy (DOE), is chartered by Congress in the America COMPETES Act of 2007 (Public Law 110–69), as amended by the America COMPETES Reauthorization Act of 2010 (Public Law 111–358), as further amended by the Energy Act of 2020 (Public Law 116–260). ARPA-E issues this Notice of Funding Opportunity (NOFO) under its authorizing statute codified at 42 U.S.C. § 16538. The NOFO and any cooperative agreements or grants made under this NOFO are subject to 2 C.F.R. Part 200 as supplemented by 2 C.F.R. Part 910. ARPA-E funds research on, and the development of, transformative science and technology solutions to address the energy and environmental missions of the Department. The agency focuses on technologies that can be meaningfully advanced with a modest investment over a defined period of time in order to catalyze the translation from scientific discovery into early-stage technology. For the latest news and information about ARPA-E, its programs and the research projects currently supported, see: http://arpa-e.energy.gov/. ARPA-E funds transformational research. Existing energy technologies generally progress on established “learning curves” where refinements to a technolog... |
||||||
| 16473 | DoW Tuberous Sclerosis Complex, Clinical Translational Research Award Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CT... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Deadline Soon Aug 6, 2026 Open | Grants.gov |
|
Source description
Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of tuberous sclerosis complex (TSC).Distinctive Features: This funding mechanism allows for multiple Principal Investigators (PIs). Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI(s) application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn. |
||||||
| 16474 | ROSES25: D.7 Strategic Astrophysics Technology NOTICE: Research security training required starting August 5, 2026. All PIs and any Co-Is that would spend ≥ 10% time on a propos... | Grant Mixed | United States | Not provided on the source page. Please check the official source. | Deadline Soon Aug 6, 2026 Open | Grants.gov |
|
Source description
NOTICE: Research security training required starting August 5, 2026. All PIs and any Co-Is that would spend ≥ 10% time on a proposed grants or cooperative agreements must certify they have taken research security training. NASA will be satisfied with the four online research security training modules on the National Science Foundation's (NSF) Research Security Training website at https://www.nsf.gov/research-security/training or the SECURE Center condensed version of the four modules at https://www.secure-center.org/ctm NOTICE: Amended May 8, 2026. This amendment releases final text for this program element, which was previously TBD. Notices of Intent are requested by June 25, 2026, and proposals are due August 6, 2026. This synopsis is a generic summary that is posted for each of the many individual "program elements" in NASA’s Research Opportunities in Space and Earth Sciences (ROSES) – 2025 solicitation. For specific information on this particular program element download and read the PDF of the text of this program element by going to Tables 2 or 3 of ROSES at https://solicitation.nasaprs.com/ROSES2025table2 and https://solicitation.nasaprs.com/ROSES2025table3, respectively, click the title of the program element of interest, a hypertext link will take you to a page for that particular program element. On that page, on the right side under "Announcement Documents" the link on the bottom will be to the PDF of the text of the call for proposals. For example, if one were interested in the Solar System Science program (NNH25ZDA001N-SCUBED) one would follow the link to the N... |
||||||
| 16475 | ROSES25: D.6 Astrophysics Research and Analysis PLEASE NOTE: this program has MANDATORY Notices of Intent, which are due via NSPIRES by June 25, 2026. See the full posting on NSP... | Grant Mixed | United States | Not provided on the source page. Please check the official source. | Deadline Soon Aug 6, 2026 Open | Grants.gov |
|
Source description
PLEASE NOTE: this program has MANDATORY Notices of Intent, which are due via NSPIRES by June 25, 2026. See the full posting on NSPIRES for details. NOTICE: Research security training required starting August 5, 2026. All PIs and any Co-Is that would spend ≥ 10% time on a proposed grants or cooperative agreements must certify they have taken research security training. NASA will be satisfied with the four online research security training modules on the National Science Foundation's (NSF) Research Security Training website at https://www.nsf.gov/research-security/training or the SECURE Center condensed version of the four modules at https://www.secure-center.org/ctm NOTICE: Amended May 8, 2026. This amendment releases final text for this program element, which was previously TBD. Mandatory Notices of Intent are due June 25, 2026, and proposals are due August 6, 2026. This synopsis is a generic summary that is posted for each of the many individual "program elements" in NASA’s Research Opportunities in Space and Earth Sciences (ROSES) – 2025 solicitation. For specific information on this particular program element download and read the PDF of the text of this program element by going to Tables 2 or 3 of ROSES at https://solicitation.nasaprs.com/ROSES2025table2 and https://solicitation.nasaprs.com/ROSES2025table3, respectively, click the title of the program element of interest, a hypertext link will take you to a page for that particular program element. On that page, on the right side under "Announcement Documents" the link on the bottom will be to the PDF of the text of the... |
||||||